United States Anemia Therapeutics Market Report 2017

November 2017 | 98 pages | ID: U3F10E930CEWEN
QYResearch

Abstracts

In this report, the United States Anemia Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Anemia Therapeutics in these regions, from 2012 to 2022 (forecast).

United States Anemia Therapeutics market competition by top manufacturers/players, with Anemia Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AMAG Pharmaceuticals
• Daiichi Sankyo
• Galenica
• Pharmacosmos
• Acceleron Pharma
• Bayer
• GlycoMimetics
• GlaxoSmithKline
• Novartis
• Pieris Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Iron
• Folic Acid Class
• Vitamin B12

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Household

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Anemia Therapeutics Market Report 2017

1 ANEMIA THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Anemia Therapeutics
1.2 Classification of Anemia Therapeutics by Product Category
  1.2.1 United States Anemia Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Anemia Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Iron
  1.2.4 Folic Acid Class
  1.2.5 Vitamin B12
1.3 United States Anemia Therapeutics Market by Application/End Users
  1.3.1 United States Anemia Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Household
1.4 United States Anemia Therapeutics Market by Region
  1.4.1 United States Anemia Therapeutics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Anemia Therapeutics Status and Prospect (2012-2022)
  1.4.3 Southwest Anemia Therapeutics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Anemia Therapeutics Status and Prospect (2012-2022)
  1.4.5 New England Anemia Therapeutics Status and Prospect (2012-2022)
  1.4.6 The South Anemia Therapeutics Status and Prospect (2012-2022)
  1.4.7 The Midwest Anemia Therapeutics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anemia Therapeutics (2012-2022)
  1.5.1 United States Anemia Therapeutics Sales and Growth Rate (2012-2022)
  1.5.2 United States Anemia Therapeutics Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANEMIA THERAPEUTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Anemia Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anemia Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anemia Therapeutics Average Price by Players/Suppliers (2012-2017)
2.4 United States Anemia Therapeutics Market Competitive Situation and Trends
  2.4.1 United States Anemia Therapeutics Market Concentration Rate
  2.4.2 United States Anemia Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anemia Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANEMIA THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Anemia Therapeutics Sales and Market Share by Region (2012-2017)
3.2 United States Anemia Therapeutics Revenue and Market Share by Region (2012-2017)
3.3 United States Anemia Therapeutics Price by Region (2012-2017)

4 UNITED STATES ANEMIA THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Anemia Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anemia Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Anemia Therapeutics Price by Type (2012-2017)
4.4 United States Anemia Therapeutics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANEMIA THERAPEUTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Anemia Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Anemia Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANEMIA THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AMAG Pharmaceuticals
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anemia Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AMAG Pharmaceuticals Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Daiichi Sankyo
  6.2.2 Anemia Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Daiichi Sankyo Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Galenica
  6.3.2 Anemia Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Galenica Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pharmacosmos
  6.4.2 Anemia Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pharmacosmos Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Acceleron Pharma
  6.5.2 Anemia Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Acceleron Pharma Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bayer
  6.6.2 Anemia Therapeutics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bayer Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 GlycoMimetics
  6.7.2 Anemia Therapeutics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GlycoMimetics Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
  6.8.2 Anemia Therapeutics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 GlaxoSmithKline Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Novartis
  6.9.2 Anemia Therapeutics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Novartis Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Pieris Pharmaceuticals
  6.10.2 Anemia Therapeutics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Pieris Pharmaceuticals Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ANEMIA THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Anemia Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anemia Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anemia Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anemia Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANEMIA THERAPEUTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Anemia Therapeutics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anemia Therapeutics Sales Volume Forecast by Type (2017-2022)
11.3 United States Anemia Therapeutics Sales Volume Forecast by Application (2017-2022)
11.4 United States Anemia Therapeutics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anemia Therapeutics
Figure United States Anemia Therapeutics Market Size (Units) by Type (2012-2022)
Figure United States Anemia Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Iron Product Picture
Figure Folic Acid Class Product Picture
Figure Vitamin B12 Product Picture
Figure United States Anemia Therapeutics Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Anemia Therapeutics by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Household Examples
Table Key Downstream Customer in Household
Figure United States Anemia Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure The West Anemia Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anemia Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anemia Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anemia Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anemia Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anemia Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anemia Therapeutics Sales (Units) and Growth Rate (2012-2022)
Figure United States Anemia Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anemia Therapeutics Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Anemia Therapeutics Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Anemia Therapeutics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anemia Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Anemia Therapeutics Sales Share by Players/Suppliers
Figure United States Anemia Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anemia Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anemia Therapeutics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anemia Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Anemia Therapeutics Revenue Share by Players/Suppliers
Table United States Market Anemia Therapeutics Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Anemia Therapeutics Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Anemia Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Anemia Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anemia Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anemia Therapeutics Product Category
Table United States Anemia Therapeutics Sales (Units) by Region (2012-2017)
Table United States Anemia Therapeutics Sales Share by Region (2012-2017)
Figure United States Anemia Therapeutics Sales Share by Region (2012-2017)
Figure United States Anemia Therapeutics Sales Market Share by Region in 2016
Table United States Anemia Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anemia Therapeutics Revenue Share by Region (2012-2017)
Figure United States Anemia Therapeutics Revenue Market Share by Region (2012-2017)
Figure United States Anemia Therapeutics Revenue Market Share by Region in 2016
Table United States Anemia Therapeutics Price (K USD/Unit) by Region (2012-2017)
Table United States Anemia Therapeutics Sales (Units) by Type (2012-2017)
Table United States Anemia Therapeutics Sales Share by Type (2012-2017)
Figure United States Anemia Therapeutics Sales Share by Type (2012-2017)
Figure United States Anemia Therapeutics Sales Market Share by Type in 2016
Table United States Anemia Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anemia Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anemia Therapeutics by Type (2012-2017)
Figure Revenue Market Share of Anemia Therapeutics by Type in 2016
Table United States Anemia Therapeutics Price (K USD/Unit) by Types (2012-2017)
Figure United States Anemia Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Anemia Therapeutics Sales (Units) by Application (2012-2017)
Table United States Anemia Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Anemia Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Anemia Therapeutics Sales Market Share by Application in 2016
Table United States Anemia Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Anemia Therapeutics Sales Growth Rate by Application (2012-2017)
Table AMAG Pharmaceuticals Basic Information List
Table AMAG Pharmaceuticals Anemia Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AMAG Pharmaceuticals Anemia Therapeutics Sales Growth Rate (2012-2017)
Figure AMAG Pharmaceuticals Anemia Therapeutics Sales Market Share in United States (2012-2017)
Figure AMAG Pharmaceuticals Anemia Therapeutics Revenue Market Share in United States (2012-2017)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Anemia Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Anemia Therapeutics Sales Growth Rate (2012-2017)
Figure Daiichi Sankyo Anemia Therapeutics Sales Market Share in United States (2012-2017)
Figure Daiichi Sankyo Anemia Therapeutics Revenue Market Share in United States (2012-2017)
Table Galenica Basic Information List
Table Galenica Anemia Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Galenica Anemia Therapeutics Sales Growth Rate (2012-2017)
Figure Galenica Anemia Therapeutics Sales Market Share in United States (2012-2017)
Figure Galenica Anemia Therapeutics Revenue Market Share in United States (2012-2017)
Table Pharmacosmos Basic Information List
Table Pharmacosmos Anemia Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Pharmacosmos Anemia Therapeutics Sales Growth Rate (2012-2017)
Figure Pharmacosmos Anemia Therapeutics Sales Market Share in United States (2012-2017)
Figure Pharmacosmos Anemia Therapeutics Revenue Market Share in United States (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Anemia Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Acceleron Pharma Anemia Therapeutics Sales Growth Rate (2012-2017)
Figure Acceleron Pharma Anemia Therapeutics Sales Market Share in United States (2012-2017)
Figure Acceleron Pharma Anemia Therapeutics Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Anemia Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Anemia Therapeutics Sales Growth Rate (2012-2017)
Figure Bayer Anemia Therapeutics Sales Market Share in United States (2012-2017)
Figure Bayer Anemia Therapeutics Revenue Market Share in United States (2012-2017)
Table GlycoMimetics Basic Information List
Table GlycoMimetics Anemia Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GlycoMimetics Anemia Therapeutics Sales Growth Rate (2012-2017)
Figure GlycoMimetics Anemia Therapeutics Sales Market Share in United States (2012-2017)
Figure GlycoMimetics Anemia Therapeutics Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anemia Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anemia Therapeutics Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Anemia Therapeutics Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Anemia Therapeutics Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Anemia Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Anemia Therapeutics Sales Growth Rate (2012-2017)
Figure Novartis Anemia Therapeutics Sales Market Share in United States (2012-2017)
Figure Novartis Anemia Therapeutics Revenue Market Share in United States (2012-2017)
Table Pieris Pharmaceuticals Basic Information List
Table Pieris Pharmaceuticals Anemia Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Pieris Pharmaceuticals Anemia Therapeutics Sales Growth Rate (2012-2017)
Figure Pieris Pharmaceuticals Anemia Therapeutics Sales Market Share in United States (2012-2017)
Figure Pieris Pharmaceuticals Anemia Therapeutics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anemia Therapeutics
Figure Manufacturing Process Analysis of Anemia Therapeutics
Figure Anemia Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Anemia Therapeutics Major Players/Suppliers in 2016
Table Major Buyers of Anemia Therapeutics
Table Distributors/Traders List
Figure United States Anemia Therapeutics Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Anemia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anemia Therapeutics Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Anemia Therapeutics Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Anemia Therapeutics Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Anemia Therapeutics Sales Volume (Units) Forecast by Type in 2022
Table United States Anemia Therapeutics Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Anemia Therapeutics Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Anemia Therapeutics Sales Volume (Units) Forecast by Application in 2022
Table United States Anemia Therapeutics Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Anemia Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anemia Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anemia Therapeutics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources